Legal
Responsible use
State the public limits of NextGenAMR.
Current status
In development. The E. coli engine is being built and will be evaluated internally under a pre-specified protocol. An independent external validation protocol has been drafted. No performance results have been published. Not for clinical use. Its scope is versioned and limited.
What NextGenAMR is not
NextGenAMR must not be used or described as an autonomous diagnosis system, a substitute for phenotypic antimicrobial susceptibility testing, or a tool that selects or recommends treatment. It does not replace professional judgement or the laboratory's reference method.
No sensitive data through public channels
Do not submit patient information, clinical records, sample identifiers, genomic files, sequences or credentials through the website or ordinary email. Any data exchange happens only through an authorised secure channel agreed in advance.
Related information
See the product scope, how it works, the evidence and the security posture for the full picture.
Related documents
Questions about this document
For questions about this notice, contact Vanguard Biotech Systems.